Revolution Medicines (RVMD) Market Cap 2020–2026
As of January 27, 2026, Revolution Medicines had a market cap of $19.3 billion, which increased by 2.12% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Revolution Medicines, Inc. (RVMD)
Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.
📈 Revolution Medicines Market Cap History by Year and Month
| Year / Month | Market Cap | % Change |
|---|---|---|
| 2026 | $19.3B | ▲ 25.32% |
| $19.3B | ▲ 25.32% | |
| 2025 | $15.4B | ▲ 89.40% |
| 2024 | $8.131B | ▲ 73.07% |
| 2023 | $4.698B | ▲ 122.13% |
| 2022 | $2.115B | ▲ 13.34% |
All market cap values reflect closing prices for the period shown.
📊 Revolution Medicines Market Cap and Other Industry Peers
Below are selected companies from the Biotechnology sector / subsector:
Data reflect the most recent market capitalization values available.
💡 What Is Market Capitalization and How Do We Calculate It?
For Revolution Medicines, Inc. (RVMD), market capitalization represents the total market value of the company’s publicly traded shares. It helps investors understand Revolution Medicines’s size within the health care sector and compare it with other companies in the same industry.
In most cases, market capitalization is calculated by multiplying the current share price by the number of basic shares outstanding. Basic shares represent the actual number of common shares that currently exist, without including potential future shares from employee stock options, RSUs, warrants, or convertible securities. For example, if Revolution Medicines had one million basic shares and each traded at $50, its market capitalization would be $50 million.
Formula:Market Cap = Share Price × Shares Outstanding
The value of Revolution Medicines’s market capitalization changes throughout the trading day because it mainly depends on the current share price. The number of shares outstanding typically remains stable unless the company issues new shares, buys back its own stock, or grants stock options to employees.
Based on the latest data, Revolution Medicines had a market capitalization of $19.3 billion, placing it in the large-cap category within the health care industry.
Disclaimer: Despite all efforts, there may still be minor inaccuracies present in the data.